RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 56-66
  • Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana

    Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana
    Nazareth police said an undercover drug buy Wednesday netted more than 50 bags of heroin, prescription painkillers and synthetic marijuana. Pedro Alexander Vera, 25, of the 1200 block of Livingston Street, Bethlehem, is charged with manufacturing...
  • Obamacare Sunshine Act sheds light on $3.5B paid to doctors

     Obamacare Sunshine Act sheds light on $3.5B paid to doctors
    U.S. doctors and teaching hospitals received nearly $3.5 billion from pharmaceutical companies and medical device manufacturers over the last five months of 2013, according to a partial set of data released Tuesday by the federal government. The data...
  • Hospira gets warning from FDA over drug manufacturing violations

    Hospira gets warning from FDA over drug manufacturing violations
    Hospira said Wednesday it received a warning letter from the Food and Drug Administration after an inspection of its Australian manufacturing facility this year identified "significant violations" of drug manufacturing practices. The warning was...
  • Baltimore joins nation in offering prescription drug take-back event

    Continuing Maryland's push to stem drug abuse, officials sought Wednesday to refocus the annual prescription "take-back" day on treatment and prevention and away from law enforcement. The nationwide take-back day — which is Saturday — has...
  • Feds to publicize drug company payments to doctors

    Feds to publicize drug company payments to doctors
    For decades, Big Pharma and medical technology firms have made gifts and other payments to physicians as part of developing, testing and marketing their products, an expense long recognized as another cost of doing business. On Tuesday, the federal...
  • Allergan likely to lose bid to stop takeover by Valeant, analyst says

    Allergan likely to lose bid to stop takeover by Valeant, analyst says
    Botox maker Allergan Inc. of Irvine appears increasingly likely to be acquired by a Canadian rival, an analyst said Tuesday. Valeant Pharmaceuticals International Inc. has been working for five months to acquire Allergan and its coveted lineup of beauty...
  • Prostate cancer drug candidate shows great promise

    Prostate cancer drug candidate shows great promise
    A white powdered chemical compound emerged from two University of Maryland School of Medicine laboratories more than 10 years ago with a name destined for oblivion, but a future that now looks promising as a treatment for the most challenging cases of...
  • Chicago misses out in AbbVie-Calico pharma deal

     Chicago misses out in AbbVie-Calico pharma deal
    A few days ago, Calico, a Google-backed biotech company, announced that it would build a California-based research and development facility to invent new drugs to combat diseases afflicting the elderly. Half of the initial $500 million investment...
  • CytRx is pouring money into R&D of cancer-fighting drugs

    CytRx is pouring money into R&D of cancer-fighting drugs
    CytRx Corp. is on a mission to cure cancer — or at least slow it down. The Los Angeles biopharmaceutical company, which recently has become embroiled in a stock-promotion controversy, specializes in researching and developing drugs to treat...
  • U.S. seeks to speed up production of Ebola drug

    U.S. seeks to speed up production of Ebola drug
    With the Ebola outbreak threatening to spiral out of control, U.S. officials unveiled a multimillion-dollar plan Tuesday aimed at getting a promising drug out of American research labs and into African hospitals and clinics more quickly. The...
  • Hospira talks for $5 billion tax inversion deal stall

    Hospira talks for $5 billion tax inversion deal stall
    Lake Forest-based drugmaker Hospira's talks to buy the medical nutrition unit of Danone and use the deal to move its tax domicile abroad have stalled, according to people familiar with the matter, as attempts by U.S. companies to relocate abroad and cut...